Who We Are

Our Network

Advancing Heart Rhythm Health

The Cardiac Arrhythmia Network of Canada (CANet) brings together healthcare professionals, academia, government, industry, not-for-profit, and patients to support new ideas and ground-breaking research.

CANet is committed to developing effective practical solutions that address unmet needs and promote their use in personal, healthcare, and business applications. Our approach is to put the right tools in the right hands at the right time, to empower:

  • Patients to manage their own health
  • Caregivers to improve patient care at the bedside and in the community
  • Healthcare providers to give timely, effective, and efficient services


Access for all Canadians to early detection, effective prevention, efficient and timely treatment of arrhythmia and related conditions, through a transformed, patient-driven care model.


Our mission is to use our internationally recognized research groups to assemble key stakeholders, work with patients and other end-users to strike key priorities, generate new knowledge about the roles of novel technology to identify patients at risk of arrhythmia, and work as a cohesive team to develop, implement, and evaluate new technologies and health strategies.


Our Networks goals and commitments are to finding innovative solutions to reduce premature death and suffering caused by heart rhythm disturbances (arrhythmias).

To view the impacts we’ve made, click here.

  1. Over the next ten years, the Network’s strategic clinical targets are:
    1. 10% drop in sudden cardiac death
    2. 20% drop in atrial fibrillation hospitalization and emergency department visits
    3. 30% drop in syncope hospitalization and emergency department visits
  2. Over the next five years, the Network’s strategic business and capacity development targets are:
    1. Commercialization of 5-7 new technologies
    2. Launch of 30-40 new experts in public and private research
  3. Significantly improve the efficiency, effectiveness, and accessibility of arrhythmia care delivery in Canada and the world.
  4. Generate $40 Million in research contributions from industry, government and not-for-profit sectors.

Our Network continues to grow with world-class researchers, collaborative partners and most important, the inclusion of patients as members on all Network committees and councils. This ensures that patient engagement continues to be an integral part of not only the design but also the implementation and evolution of the Network’s strategic plan.

Dr. Anthony Tang
Scientific Director and CEO, Cardiac Arrhythmia Network of Canada

CANet Publications

Need More Info?

Interested in joining the CANet team?

Yes, please subscribe me to the CANet newsletter